» Articles » PMID: 20421330

Estimates of the Impact of Diabetes on the Incidence of Pulmonary Tuberculosis in Different Ethnic Groups in England

Overview
Journal Thorax
Date 2010 Apr 28
PMID 20421330
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is good evidence that diabetes is a risk factor for pulmonary tuberculosis. In England, the rates of both diabetes and tuberculosis vary markedly by ethnic group.

Objective: To estimate the proportion of incident cases of pulmonary tuberculosis attributable to diabetes (population attributable fraction, PAF) for Asian, black and white men and women aged > or = 15 years in England.

Methods: An epidemiological model was constructed using data on the incidence of tuberculosis, the prevalence of diabetes, the population structure for 2005 and the age-specific relative risk of tuberculosis associated with diabetes from a large cohort study.

Results: The estimated PAF of diabetes for pulmonary tuberculosis is highest for Asian men (19.6%, 95% CI 10.9% to 33.1%) and women (14.2%, 95% CI 7.1% to 26.5%). The PAF for all ages is similar in white and black men (6.9%, 95% CI 3.1% to 12.4% and 7.4%, 95% CI 4.6% to 12.9%, respectively) and women (8.2%, 95% CI 3.0% to 15.6% and 8.9%, 95% CI 5.3% to 15.6%, respectively). The similarity of these overall figures, despite a higher prevalence of diabetes in the black population, reflects a much younger mean age of pulmonary tuberculosis in the black population. Overall, of 3461 new cases of pulmonary tuberculosis in England in 2005, 384 (202-780) were estimated to be attributable to diabetes.

Conclusion: Given the nature of the data available, considerable uncertainty surrounds these estimates. Nonetheless, they highlight the potential importance of diabetes as a risk factor for pulmonary tuberculosis, particularly in groups at high risk of both diseases. Further research to examine the implications of these findings for tuberculosis control is urgently needed.

Citing Articles

Elderly Patients with Tuberculosis Combined with Diabetes Mellitus: A Comprehensive Analysis of Lymphocyte Subpopulation Dynamics, Clinical Features, Drug Resistance and Disease Regression.

Wang X, Song Y, Li N, Huo J, Wang B, Jiang X Int J Gen Med. 2025; 18:1271-1282.

PMID: 40065980 PMC: 11892736. DOI: 10.2147/IJGM.S502996.


Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective.

Ye Z, Li L, Yang L, Zhuang L, Aspatwar A, Wang L Exploration (Beijing). 2024; 4(5):20230138.

PMID: 39439490 PMC: 11491313. DOI: 10.1002/EXP.20230138.


Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries.

Abbas U, Masood K, Khan A, Irfan M, Saifullah N, Jamil B J Clin Tuberc Other Mycobact Dis. 2022; 29:100343.

PMID: 36478777 PMC: 9720570. DOI: 10.1016/j.jctube.2022.100343.


Engagement of private healthcare providers for case finding of tuberculosis and diabetes mellitus in Pakistan.

Habib S, Rafiq S, Jamal W, Ayub S, Ferrand R, Khan A BMC Health Serv Res. 2020; 20(1):328.

PMID: 32306961 PMC: 7168982. DOI: 10.1186/s12913-020-05217-2.


Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: A population-based cohort study.

Pan S, Yen Y, Feng J, Chuang P, Su V, Kou Y Br J Clin Pharmacol. 2019; 86(3):569-579.

PMID: 31633826 PMC: 7080625. DOI: 10.1111/bcp.14142.